Patents by Inventor Marco Mantovanini

Marco Mantovanini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6887903
    Abstract: The compounds of formula 1 wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: May 3, 2005
    Assignee: Dompe S.p.A.
    Inventors: Riccardo Bertini, Cinzia Bizzarri, Vilma Sabbatini, Gianfranco Caselli, Marcello Allegretti, Maria Candida Cesta, Carmelo Gandolfi, Marco Mantovanini, Francesco Colotta, Stefano Porzio
  • Patent number: 6881755
    Abstract: The compounds of formula 1, wherein R and R2 are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: April 19, 2005
    Assignee: Dompé S.p.A.
    Inventors: Riccardo Bertini, Cinzia Bizzarri, Vilma Sabbatini, Gianfranco Caselli, Marcello Allegretti, Maria Candida Cesta, Carmelo Gandolfi, Marco Mantovanini, Francesco Colotta, Stefano Porzio
  • Patent number: 6770781
    Abstract: A process for the preparation of meta or para-substituted &agr;-arylalkanoic acids of formula (I) wherein R and R1 are as defined in the disclosure.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: August 3, 2004
    Assignee: Dompe′ S.p.A
    Inventors: Marcello Allegretti, Maria Candida Cesta, Marco Mantovanini, Luca Nicolini
  • Publication number: 20030216392
    Abstract: The compounds of formula 1, 1
    Type: Application
    Filed: June 13, 2003
    Publication date: November 20, 2003
    Applicant: Dompe S.p.A.
    Inventors: Riccardo Bertini, Cinzia Bizzarri, Vilma Sabbatini, Gianfranco Caselli, Marcello Allegretti, Maria Candida Cesta, Carmelo Gandolfi, Marco Mantovanini, Francesco Colotta, Stefano Porzio
  • Patent number: 5908863
    Abstract: Compounds of formula I: ##STR1## wherein R.sub.a, R.sub.b, .PHI., B and R are as defined in the disclosure, have antagonistic activity on osteoclast hyper-reactivity.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: June 1, 1999
    Assignee: Dompe' S.p.A.
    Inventors: Marcello Allegretti, Marco Mantovanini, Gianfranco Caselli, Simonetta Fiorentino, Gaetano Clavenna, Carmelo A. Gandolfi
  • Patent number: 5808069
    Abstract: The salts of S(+) 2-(3-benzoylphenyl)propionic acid and of R(-) 2-(3-benzoylphenyl)propionic acid with an organic base such as D-lysine, L-lysine, L-arginine, (R) 3-(4-phenylpiperazin-1-yl)propane-1,2-diol and (S) 3-(4-phenylpiperazin-1-yl)propane-1,2-diol, the process for their preparation and the corresponding pharmaceutical compositions containing said salts are described.
    Type: Grant
    Filed: October 31, 1995
    Date of Patent: September 15, 1998
    Assignees: Dompe' Farmaceutici SpA, Dimpe' SpA
    Inventors: Enrico Bosone, Gaetano Clavenna, Carmelo Gandolfi, Marco Mantovanini, Roberto Curti
  • Patent number: 5773465
    Abstract: Tartronic acid acetalic ethers and esters of the general formula: ##STR1## are provided and are useful in treatment of bone dysmetabolism. As examples, Ra and Rb may be hydrogen, B is a C.sub.2 -C.sub.12 acyl group, R is phenyl and n is 0-12.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: June 30, 1998
    Assignee: Dompe Farmaceutici S.p.A.
    Inventors: Carmelo A. Gandolfi, Lorella Cotini, Marco Mantovanini, Gianfranco Caselli, Gaetano Clavenna, Claudio Omini
  • Patent number: 5750536
    Abstract: Tropyl 7-azaindol-3-ylcarboxamides of the formula ##STR1## or their N-oxides of the formula ##STR2## wherein R is hydrogen, alkyl, cyclo-alkyl, arylalkyl or acyl, are particularly effective as antitussive agents.
    Type: Grant
    Filed: April 2, 1996
    Date of Patent: May 12, 1998
    Assignee: DOMPE ' SpA
    Inventors: Marco Mantovanini, Gabriella Melillo, Luisa Daffonchio
  • Patent number: 5656656
    Abstract: Tartronic acid acetalic ethers and esters of the general formula: ##STR1## are provided and are useful in treatment of bone dysmetabolism. As examples, Ra and Rb may be hydrogen, B is a C.sub.2 -C.sub.12 acyl group, R is phenyl and n is 0-12.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: August 12, 1997
    Assignee: Dompe Farmaceutici S.p.A.
    Inventors: Carmelo A. Gandolfi, Lorella Cotini, Marco Mantovanini, Gianfranco Caselli, Gaetano Clavenna, Claudio Omini
  • Patent number: 5436262
    Abstract: Derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane, the process for their preparation as well as the pharmaceutical compositions containing them as active ingredients are described. The compounds exhibit anti-allergic activity.
    Type: Grant
    Filed: May 16, 1994
    Date of Patent: July 25, 1995
    Assignee: Dompe Farmaceutici SpA
    Inventors: Marco Mantovanini, Roberto Curti